Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma

NCT03013010 2025-12-08

PREACT

Phase 3 Completed

204 enrolled

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT03813784 2025-09-16

A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

Phase 3 Completed

885 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02872116 2025-08-07

CheckMate649

Phase 3 Completed

2,031 enrolled 19 charts 1 FDA

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT01815853 2025-07-03

Neo-CRAG

Phase 3 Completed

620 enrolled

Gastrointestinal

Stomach Neoplasms

NCT04032119 2025-05-04

RCT of Gastric ESD With or Without Epineprhine Added Solution

Phase 3 Completed

800 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02349412 2025-02-07

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

Phase 3 Completed

405 enrolled 11 charts

GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Anxiety Disorders, Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Depression, Esophageal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT02578368 2024-11-12

FLOT5

Phase 3 Completed

183 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02845479 2024-09-20

POISE

Phase 3 Completed

22 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Stomach Neoplasms

NCT00400179 2024-09-19

A Safety and Efficacy Study in Patients With Gastric Cancer

Phase 3 Completed

1,053 enrolled 18 charts

Gastrointestinal

Stomach Neoplasms

NCT02500043 2024-09-03

Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

Phase 3 Completed

507 enrolled 17 charts 1 FDA

Gastrointestinal

Stomach Neoplasms

NCT01839773 2024-07-25

DREAM

Phase 3 Completed

238 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02267343 2024-05-03

Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer

Phase 3 Completed

493 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03006705 2024-05-03

Study of Adjuvant ONO-4538 With Resected Gastric Cancer

Phase 3 Completed

800 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01924533 2024-03-22

Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.

Phase 3 Completed

525 enrolled 26 charts

Gastrointestinal

Stomach Neoplasms

NCT01515748 2023-12-13

PRODIGY

Phase 3 Completed

530 enrolled 11 charts

Gastrointestinal

Stomach Neoplasms

NCT02178956 2023-11-15

BRIGHTER

Phase 3 Completed

714 enrolled 16 charts

Gastrointestinal

Stomach Neoplasms

NCT02853474 2023-04-26

EPIC-1511

Phase 3 Completed

480 enrolled

Gastrointestinal

Bile Duct Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT02494583 2023-04-13

MK-3475-062

Phase 3 Completed

763 enrolled 29 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT03745170 2023-03-01

Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer

Phase 3 Completed

650 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03042611 2022-07-08

ANGEL

Phase 3 Completed

460 enrolled 16 charts

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT02370498 2022-06-06

MK-3475-061

Phase 3 Completed

592 enrolled 37 charts

Gastrointestinal

Stomach Neoplasms

NCT02322593 2021-12-20

SOLAR

Phase 3 Completed

711 enrolled 16 charts

Gastrointestinal

Gastrointestinal Diseases, Gastrointestinal Neoplasms, Stomach Neoplasms

NCT02395640 2021-10-26

The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer

Phase 3 Completed

438 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02158988 2021-07-29

GASTRIPEC

Phase 3 Completed

105 enrolled

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT03196791 2021-07-12

Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient

Phase 3 Completed

196 enrolled 11 charts

GastrointestinalOther

Obesity, Stomach Neoplasms

NCT00002883 2021-02-23

Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus

Phase 3 Completed

250 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT01774786 2020-12-30

JACOB

Phase 3 Completed

780 enrolled 24 charts

Gastrointestinal

Stomach Neoplasms

NCT02625623 2020-11-24

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Phase 3 Completed

371 enrolled 18 charts

Gastrointestinal

Recurrence, Stomach Neoplasms

NCT02114359 2020-10-23

Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer

Phase 3 Completed

111 enrolled

Gastrointestinal

Stomach Neoplasms

NCT00020787 2020-08-03

Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer

Phase 3 Completed

8 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT02545504 2020-05-26

GAMMA-1

Phase 3 Completed

432 enrolled 19 charts

Gastrointestinal

Stomach Neoplasms

NCT00052910 2020-05-07

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

Phase 3 Completed

546 enrolled 11 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00016380 2020-04-03

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Phase 3 Completed

211 enrolled

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Nausea, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Seminoma

NCT01248403 2020-01-29